| 000 | 00692nam a2200205 ib4500 | ||
|---|---|---|---|
| 001 | D0001J001503 | ||
| 003 | DOH | ||
| 005 | 20241002093012.0 | ||
| 008 | 241002t ||||| |||| 00| 0 eng d | ||
| 100 | 1 | _aLindeborg, Michael M. | |
| 245 | 0 | 0 |
_aPrevention and management of hearing loss in patients receiving ototoxic medication / _cBy: Michael M. Lindeborg [and three others] |
| 580 | _aBulletin of the World Health Organization 2022 100(12) 789-796 | ||
| 650 | 0 | 2 | _aDeafness |
| 650 | 0 | 2 | _aHearing Loss |
| 650 | 0 | 2 |
_aHearing Loss _vprevention & control |
| 650 | 0 | 2 | _aOtotoxicity |
| 650 | 0 | 2 |
_aOtotoxicity _vprevention & control |
| 650 | 0 | 2 | _aTuberculosis, Multidrug-Resistant |
| 942 | _cJA | ||
| 999 |
_c6617 _d6617 |
||